Last Updated: August 3, 2026

PRAVIGARD PAC (COPACKAGED) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pravigard Pac (copackaged), and what generic alternatives are available?

Pravigard Pac (copackaged) is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in PRAVIGARD PAC (COPACKAGED) is aspirin; pravastatin sodium. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; pravastatin sodium profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PRAVIGARD PAC (COPACKAGED)?
  • What are the global sales for PRAVIGARD PAC (COPACKAGED)?
  • What is Average Wholesale Price for PRAVIGARD PAC (COPACKAGED)?
Summary for PRAVIGARD PAC (COPACKAGED)
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:PRAVIGARD PAC (COPACKAGED) at DailyMed

US Patents and Regulatory Information for PRAVIGARD PAC (COPACKAGED)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET;ORAL 021387-001 Jun 24, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET;ORAL 021387-004 Jun 24, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET;ORAL 021387-002 Jun 24, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET;ORAL 021387-003 Jun 24, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET;ORAL 021387-006 Jun 24, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bristol Myers Squibb PRAVIGARD PAC (COPACKAGED) aspirin; pravastatin sodium TABLET;ORAL 021387-005 Jun 24, 2003 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for PRAVIGARD PAC (COPACKAGED)

See the table below for patents covering PRAVIGARD PAC (COPACKAGED) around the world.

Country Patent Number Title Estimated Expiration
Austria 374495 ⤷  Start Trial
Austria A256781 ⤷  Start Trial
Australia 549988 ⤷  Start Trial
Australia 7137681 ⤷  Start Trial
Belgium 889150 ⤷  Start Trial
Canada 1150170 DERIVES DE ML-236B ET LEUR PREPARATION (ML-236B DERIVATIVES AND THEIR PREPARATION) ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.